From our Ask the Expert series, CLL expert Dr. Michael Keating of MD Anderson Cancer Center answers a common CLL question: Do inhibitor treatments have to be a lifelong medicine? Listen as Dr. Keating describes his personal disinclination for what he refers to as just controlling the disease and how he anticipates immunotherapy strategies being used to eventually eradicate CLL.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Advertisement